Congress

Lots of marijuana policy news today, plus GOP Rep. James Sensenbrenner files a bill to reauthorize the Second Chance Act.

Florida lawmakers finally reach agreement on implementing the medical marijuana constitutional amendment, Colorado's governor signs an asset forfeiture reform bill, and more.

Drug overdoses are at an all time high, drug war dinosaur senators want to return to harsh sentencing, Wisconsin's GOP governor moves forward with first in the nation plan to drug test Medicaid applicants, and more.

Dianne Feinstein and Chuck Grassley file a CBD research bill, Detroit has been moving against unpermitted dispensaries, and more.

A bipartisan group of US senators has sent Attorney General Sessions a letter asking him to rein in federal civil asset forfeiture, the Rhode Island House is voting on a pot legalization study commission, the Canadian parliament begins debating the government's legalization bill, and more.

France is moving toward marijuana decriminalization, perhaps as early as September, Vermont legalization supporters still hold out hope, and more.

Marijuana policy continues to motivate members of Congress, a leading drug testing firm reports that positive worker drug tests are on the rise, Maryland's first medical marijuana cultivator gets final approval to grow, and more.

The Rhode Island House voted to study marijuana legalization instead of actually do it, Vermont newspapers pressure the governor to sign their legalization bill, the federal Justice Safety Valve Act gets refiled, Mexican journalist Javier Valdez Cardenas is gunned down, and more.

Marijuana legalization efforts look stalled in Connecticut and Rhode Island, Rand Paul joins the chorus of critics of Attorney General Sessions' drug war crackdown, the California Senate approves a bill to end sentencing enhancements for prior drug convictions, and more.

A legalization bill in Vermont awaits the governor's signature, and so does a decrim bill in New Hampshire, Trump names an anti-reform drug commission, Senate Democrats signal their concerns over Trump drug policies, and more.